INTRODUCTION
Molecular biologists developing assays face complex challenges inherent with the rate of new target identification and their adaptation to automation-ready assays. In addition, the exponential growth of compound libraries over the last several years has required that assays be miniaturized as a means of containing costs.
Using AAO, the assay developer can take advantage of statistical design of experiment (a.k.a. DOE or experimental design) to create more robust, cost-effective assays. Making assays more robust for automated systems no longer has to be a bottleneck because AAO lets the scientist concentrate on the science, not the mundane tasks of pipetting or writing complex liquid handling methods.
AAO combines the power of statistically designed experiments with the flexibility of the Biomek 2000 and post-run data collection and analysis. No longer is the DOE approach to assay development cumbersome and impractical.
STATISTICAL EXPERIMENTAL DESIGN
In pharmaceutical and biotechnology industries, winning the race to market depends on advancing discovery quickly and economically. Since it can take thousands of tests to discover just one drug candidate, the cost of time, people, equipment, and testing resources expands as the number of experiments rises. Automation in the laboratory has helped by using machines to perform tasks that do not require the human involvement. However, automation alone will not meet all challenges, some challenges are best met by designing better experiments. This can be accomplished by utilizing the powerful tools provided by statistical experimental design. AAO uses statistical experimental design to improve the speed and economics of assay development and implementation.
Statistical experimental designs are collections of settings to use for experimental factors (e.g., incubation time, buffer pH, buffer concentration, etc.). The designs are created such that certain mathematical properties are maintained. These properties allow experiments to separate signals from one another and from background noise. This isolation of signals allows confident detection of the effects due to each experimental factor.
In general, a datum collected from an experiment is comprised of several components. These include the signal generated by each individual experimental factor, the signal generated by interactions between two factors at a time, three factors at a time, etc., and a noise component. The noise component consists of things like experimental error and background noise. Mathematically, we can express this as:
Detected value = Factor A signal + Factor B signal + … + A and B interaction + … + noise or more concisely as: Y = A + B + … + AB + … + noise Note that the term "interaction" has different meaning in the mathematics of DOE than it does in chemistry. In DOE, it means the effect on detected value due solely to the combination of the factors involved. For instance, changing temperature may affect a reaction rate and so might catalyst concentration. These would be the "A" and "B" values above where "Y" is reaction rate. The "AB" term would be the combined effect of changing temperature and concentration together, which may be a more profound effect, and is treated as a mathematically separate item. their high value; the rest of the factors are set to their low values. The letter "i" is used to represent the experiment in which all factors are set to their low values. Thus, the experiment in which factors A and C are set high and factor B is set low is shown as "ac" in the graph. The settings used for experiments are called treatment conditions.
If we want to determine the effect that a particular factor has, say factor C, we can run all 8 experiments, measure the results, and then estimate the effect as follows. Assign the measured response of each experiment to its treatment condition letter sequence. The effect due to factor C can be estimated as the average difference in measured effects between the experiments where C is set high and where C is set low. This becomes the equation C=[(c-i)+(ac-a)+(bcb)+(abc-ab)]/4, which reduces to C=[-i-a-b+c-ab+ac+bc+abc]/4. (The significance of the order of the addends is explained below.) Other effects can be estimated in a similar manner.
Effects due to interactions between factors can also be estimated. For instance, the interaction effect AC can be calculated as half the difference between the average effect due to A at the two levels of C. So the effect of A when C is set high is calculated as A(C+)=[(ac-c)+(abc-bc)]/2 and the effect of A when C is set low is calculated as A(C-)=[(a-i)+(ab-b)]/2. This becomes the equation AC={[(ac-c)+(abc-bc)]/2-[(a-i)+(ab-b)]/2}/2, which reduces to [ia+b-c-ab+ac-bc+abc]/4. If we examine the equations for C and AC, we notice that both have all of the treatment conditions listed in the numerator, but with different signs. These are called contrasts. When all of the effect equations are created and the signs of their contrasts are examined, a clear pattern emerges (see Table 1 ). We can see that the contrast for an interaction is found by multiplying the signs of the contrasts for the associated main effects. For example, the AB interaction contrast is found by multiplying the A contrast signs by the B contrast signs. Therefore, the i term for the AB contrast is +i, because A and B are both negative for the i term and negative times negative is positive.
FRACTIONAL FACTORIAL DESIGN
It becomes obvious that for a large number of factors, full factorial designs are not practical due to the large number of experiments necessary. For this reason, fractional factorial designs are used. Fractional factorial designs use a systematic approach that takes advantage of accepted experimental assumptions. As implied, these designs require a fraction of the number of experiments necessary for full factorial designs. For our example, there are two _ fractions of the 2 3 full factorial design, as noted in Figure 1 . If we examine the fraction indicated by the blue diamonds, we see that they correspond to the experiments that have all plus signs for the ABC effect. Thus, ABC is said to define this _ fraction. Looking at the contrasts for this _ fraction as indicated in Table 1 , we see that A=[a-b-c+abc]/2, which is exactly the same effect estimate equation as BC. Thus, when we calculate the estimated effects due to A and due to the BC interaction, we cannot tell them apart. When effects are indistinguishable in this way, they are said to be aliased. Aliasing of effects is the price we pay for doing only half of the experiments. This is acceptable if interaction effects are thought to be insignificant compared to primary effects.
The fractional factorial design can produce results that include the following:
· Providing estimates of how strongly factors affect experimental performance, including identification of ineffective factors · Studying many applicable factors simultaneously using a minimal number of observations
· Finding important interactions among factors
Fractional factorial designs eliminate the necessity for costly one-factor-at-a-time experiments that test each factor individually. You certainly may find a solution to some problems, but every cycle of the experiment typically answers one question at a time, requiring an excessively large number of measurements to solve your research problem. These designs commonly misuse resources and risk not covering the experimental space. This can result in the possibility of missing the crucial discovery. If you know the ranges to use for factors, fractional factorial designs can take into account the entire relevant experimental space. Using fractional factorial designs, you end up with nearly the same information at a fraction of the cost.
THE CONCEPT OF DESIGN RESOLUTION
The resolution of an experimental design refers to its completeness with respect to the combinations of settings for all of its factors. The resolution of a design directly impacts its analysis. Fractional designs are frequently described by a resolution number, usually III, IV, or V. The resolution number is the sum of the size of the factor interactions that can be aliased. For example, a resolution III design can have main effects aliased with two-factor interactions. Interactions among more than two factors can also be aliased. A resolution IV design, however, can have main effects aliased with three-factor interactions, but not two-factor interactions; and can have two-factor interactions aliased with each other. Design resolution is selected according to the desired results of an assay. If information about interactions is required, a higher resolution design is needed.
Resolution III
Resolution III is the lowest useful resolution, although with resolution III designs it is not possible to distinguish between main effects and effects due to interactions between factors. For example, if A is aliased with the BC interaction, it is impossible to determine if the settings for factor A or the combination of the settings for B and C made the biggest difference. For resolution III designs, main effects are aliased with two-factor interactions and two-factor interactions may be aliased with each other. For exam- Table 1 . Contrasts for Estimating Effects ple, if factors A, B, and C are used, the effect due to factor A may be aliased with the BC interaction effect, but it will not be aliased with the effects of B or C individually. It is also possible that the AB interaction and the BC interaction will be aliased.
Resolution IV
Resolution IV designs have a larger number of experiments to be performed, however, more information about interactions is discernible. Specifically, it is possible to distinguish main effects from interaction effects, although it is not possible to distinguish interaction effects from one another. For example, it may be possible to tell that the setting for factor A made the biggest difference. However, it is not known if further differences are because the settings for A and B interact or because the settings for B and C interact. Main effects are not aliased with each other or with twofactor interaction effects in a resolution IV design; however, twofactor interaction effects may be aliased with each other. For example, considering factors A, B, and C, the effect due to factor A cannot be aliased with B or C by themselves or with the BC interaction effect. However, A may be aliased with the ABC three-factor interaction effect. It is also possible that the AB interaction and the BC interaction will be aliased.
Resolution V
Resolution V designs have a larger number of experiments to be performed, but allow isolation of main effects and two-factor interactions. Thus, it is possible to distinguish main effects from interaction effects and two-factor interaction effects from each other. That is, it is possible to tell that the settings for factor A made the most difference and that the settings for B and C interact to produce a significant difference. No main effects and no two-factor interaction effects are aliased with each other in a resolution V design, but two-factor interaction effects may be aliased with three-factor interaction effects. For example, considering factors A, B, C, D, and E, the effect due to factor A cannot be aliased with B or C by themselves or with the BC interaction effect. However, A may be aliased with the BCDE four-factor interaction. Also, the AB interaction and the BC interaction effects cannot be aliased, but AB could be aliased with the CDE interaction effect.
Applying Fractional Factorial DOE
Experimental design produces an experiment set, which must be related to physical settings in order to conduct the experiments. The choice of settings for each factor is left to the assay developer, who must use experience and scientific judgment to ensure that factors are kept within an appropriate operating range. In addition, the experiments in an experiment set must be randomized to prevent introduction of systemic bias into the results. For instance, if some part of a plate seems to give a higher signal in the plate reader, there should be no predisposition as to the settings used for those wells. Likewise, pipetting irregularities, evaporation, crosscontamination, human error, etc., should not be connected with a particular setting in any way. By randomizing the experiments performed, many unintentional variations will appear as random noise or experimental error, and will not be confused with effects due to experimental factors. Unfortunately for previous researchers, this randomization makes liquid handling and data acquisition particularly complex. Pipetting aliquots to random locations on plates by hand is tedious, time consuming, and error prone work. Likewise, programming a liquid handling robotic system to do the pipetting is little better, though more easily repeatable and more accurate. After experiments have been performed and assay results are collected, the deconvolution of data from random locations to a suitable order for analysis is nontrivial. It is for these reasons that research and development in AAO has been conducted.
OVERVIEW OF THE AAO PROCESS
The AAO process consists of five stages for attaining effective assay results (see Figure 8 ):
1) Design the experiments. In this stage the researcher chooses from among factors to be studied (e.g., buffer composition, incubation temperatures, plate color, etc.). In addition, the assay developer decides what resolution of fractional factorial design will be used. Lastly, the researcher enters information about the experimental design parameters (e.g., whether to exclude regions of the plate or if quality control wells are included on each plate).
2) Generate the plate maps for the experiment set. Once experiments are designed, the software automatically generates a statistical model of the experiment. Using sophisticated algorithms, the software creates randomized plate maps for the experiment set. This mapping also takes into account plate restrictions and experimental protocol.
3) Create the Biomek 2000 liquid handling methods. After experiment plate maps are generated, the AAO software guides the creation of Biomek 2000 methods for liquid handling. During this stage the researcher has control over the order of pipetting and associated parameters (e.g., volume, tip touch, etc.). The software also provides the assay developer with the ability to add reagents common to all experiments and to create the various intermediate buffer mixtures to use throughout the experiments. 4) Perform the assay. Once the Biomek methods are prepared, the researcher runs the assay. During this stage, the scientist is responsible for manipulating the plates, including loading them on the Biomek and other devices such as a shaker, incubator, etc. Once plates are on the Biomek deck, the appropriate methods are run in the order needed for the assay.
5) Collect the data and analyze results. After the assay is completed, the data is collected. This process can be automated through the AAO software with one of several compatible plate readers. Automatic data collection enters data into Microsoft Excel in a user-readable format for analysis. If a non-compatible reader is chosen, then the data must be entered into Excel through text file import, writing a data logging macro, or by typing in the results. Once the data is entered into Excel, standard analyses are performed to estimate the effects of the various factors under study. In addition, designs of resolution greater than III can include interactions between pairs of factors. Using Excel to perform the analysis gives added flexibility for analysis since formulas used for analysis are provided and can be modified or new ones inserted as required.
The AAO user interface permits intervention in the flow-ofcontrol process at any logical point. For instance, if an assay already has been made, the assay developer can jump in and start in the middle of stage 1, modifying the factors to be studied. If an experiment set has been made, the process can be started at the pipetting stage.
A MORE DETAILED LOOK AT HOW SAGIAN™ AAO WORKS
(1) Design the Experiments An experiment set is created for an assay by selecting an appropriate type of experimental design. The criteria for making this selection are design resolution, number of experiments, assay protocol, plate layout, and number of replicates.
AAO presents information about the consequences of design choices. Based on the design resolution chosen, AAO describes how main effects and interaction effects can be estimated by analysis. In addition, AAO indicates the number of experiments to be performed and the number of plates required.
Assay Type
The assay developer has three choices for choosing an assay type, pre-defined, custom, or based on a previously designed assay. The six predefined assays included within AAO are receptor-membrane, receptor-soluble, enzyme-cleavage, enzyme-transferase, cellcalcium and cell-reporter. Each of the predefined assays includes a list of factors consistent for that type of assay.
Alternately, the assay developer can create a custom assay. This can be done by starting with a blank template, with no pre-established factors, or a composite template that contains the combined factors of all of the six predefined assay templates.
Lastly, the assay developer can start with a previously designed assay. This assay will contain the factor information stored the last time the assay was saved. Assays can be overwritten or stored under a new name.
Factors
Upon selecting an assay type, the factor selection screen is displayed. On this screen, the researcher enters the assay name, designer name, and any comments or descriptive information. Next, the researcher selects the factors to be included in the study. In AAO, factors (i.e., parameters or variables) are grouped into three categories, inter-plate, buffer, and reagent (other). Inter-plate factors include variables such as incubation temperature, incubation duration, and plate type and color. Buffer factors include variables such as pH, concentration, and composition. Reagent factors include variables such as the presence of a stabilizer or choice of enzyme.
Factors included in the assay template selected by the scientist will be shown in the table on the factor selection screen. The scientist can choose to view factor types independently or in combination. The list of factors in the table is fully editable. Factors can be modified, added, or removed. In fact, completely new assay types can be formed by changing the default list of factors.
For each factor, two levels will be set for the experiment (e.g., present/absent, green/blue, or high/low). The scientist must ensure the two levels cover an appropriate operating range. If the range is too small, the differences in effects may be negligible. At the same time, if the levels are set too far apart, they may fall out of a normal operating range. Lastly, if the response to the factor is nonlinear, the factor may be important despite results that show the levels studied had no effect.
Once a suitable list of factors is established, the researcher simply selects the factors from the list for inclusion in the study. Only the desired factors for the study need to be selected. The researcher must keep in mind that selecting a large number of factors will result in a larger number of experiments, thus consuming more time and resources. Lastly, the researcher must ensure that those factors not selected, as well as other experimental conditions, remain constant between experiments.
AAO limits the selection of factors for a single experiment set to 25, however it is recommended that at most 10 factors be included in each experiment set.
Design Resolution
AAO provides four levels of design resolution, full factorial Full-factorial design is the highest resolution supported by AAO. In full-factorial design, 2 n experiments are generated, creating an experiment for each combination of the n factor settings. Full factorial design should be chosen when analysis of higher order interactions is necessary. Frequently, many full factorial experiments are not necessary to obtain the desired informatio n. For these applications, lower resolution designs can be used.
The principle behind fractional factorial designs is to do a fraction of the 2 n experiments, while retaining as much information as possible about factors and lower order interactions.
The three resolutions of fractional factorial designs included are III, IV, and V. Resolution III is the lowest resolution supported by AAO, it provides information only about main effects. Resolution III designs do not allow the analysis of interaction effects. Resolution IV is an appropriate choice to isolate main effects from interaction effects. However, it will not distinguish effects due to interactions from one another. Resolution V enables the researcher to isolate main effects from interaction effects. It can also distinguish two-factor interaction effects from each other, however it can not distinguish two-factor interactions from three-factor interactions.
As illustrated in Figure 2 and Table 2 , the design resolution and number of experiments (with associated number of plates and amounts of reagents) are intertwined -specifying one affects the choices available for the other. A reasonable goal when choosing design parameters might be to have less than 700 experiments on eight to ten plates.
Protocol
The assay protocol can be one of Totals, Totals and Background, or Totals, Background and Standard. Totals correspond to those experiments measured as the "signal" component of an experiment set. Totals will result in one well per experiment. Background corresponds to those experiments measured as the "background" or "noise" component of an experiment set. Totals and Background will result in two wells per experiment. Standard corresponds to those experiments measured as the "baseline" component of an experiment set. Totals, Background and Standard will result in three wells per experiment.
Quality Control Wells
A quality control well is simply a well set aside for experiments completely controlled by the assay developer. Facilities are provided within AAO for pipetting into the quality control wells. The maximum number of quality control wells allowed per plate is 24.
Replicates
The number of replicates is simply the number of times each experiment is repeated. Choosing to replicate experiments helps the statistics by determining an error term for the experiments. The maximum number allowed is 10.
Well Use Restrictions
AAO supports both 96-well and 384-well plates. Only a single plate size can be used in a given experiment set. When using 384-well plates, only 96 wells or one quadrant of the plate will be used for experiments. Experiments that have common "inter-plate" factors will be assigned random locations on the same plate, space permitting, including any replicates of those experiments. The assay developer may exclude the outer rows, outer columns, or both if edge effects are suspected. This reduces the number of wells that can be assigned an experiment.
Plate maps are generated which show how each well will be treated in the experiment, including plate parameters, buffer composition, reagent additions, incubations, and other treatments.
(2) Generate Plate Maps
Once experiments are designed, AAO will automatically map the experiments to microplates and then display the maps in a user-friendly format (see Figure 3) .
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Number of Factors

Creating an Experiment Set
AAO creates an experiment set that satisfies the experimental design specified by the assay developer. This includes the statistical model, inter-plate and intra-plate factors, the selected protocol, quality control wells, replicates, and well-use restrictions. The result is a complete list of experiments that will need to be assigned to wells.
Experiment Assignments
Next, AAO evaluates how many wells per plate are available to be filled with experiments. Using a sophisticated algorithm, the software creates truly randomized plate maps for the experiments. The algorithm will randomly fit the experiments into the plates in the most efficient manner possible while maintaining the experimental design.
Once the experiments have been assigned, the software presents a text version of the experiment design, as well as a graphical view of the experiment plates. The text view shows the experiment set parameters chosen by the assay developer, the alias structure of the experiment, and other useful information. The graphical view is a color-coded representation of each well on a plate. The researcher can change the view from one plate to the next. In addition, the researcher can choose to view the factor assignments or buffer mixture assignments for the wells on a given plate. Highlighting any individual well on a plate will give a complete listing of the well contents, as well as the inter-plate factors.
(3) Create Bioworks Methods
AAO will facilitate the creation of liquid handling methods for the Biomek 2000. These methods will be executed by the researcher in the proper sequence during the next stage of the process. In order for AAO to create the Bioworks methods, the assay developer must enter a minimal amount of information. Once this information has been entered, AAO will automatically create methods that correspond with the experiment assignment generated in the previous stage.
Deck Layout
First, the researcher defines the Biomek 2000 deck layout (see Figure 4) . This is done by indicating where deck components such as tools, tips, sources and destination labware are located. It is important to note that AAO only supports the use of single probe tools. Therefore, at least on single probe tool is required for the system to work properly. To increase the number of available deck locations, AAO supports the use of the Biomek 2000 side modules. 
Buffer Mixtures
Next, the assay developer has two options for introducing the buffer components into experimental wells. The first option is to pipette the required amounts of buffer stocks directly into the experiment wells. The second option is to prepare intermediate buffer mixtures in a separate piece of labware and then to pipette a single aliquot of the pre-mixed buffer solutions into the experiment wells.
If the assay developer chooses the second option, AAO will create the Bioworks methods needed to create the intermediate buffer mixtures. The advantage of creating the intermediate buffer mixtures is that a large volume of buffer mixture is created for addition to all experiments with the same buffer composition. Thus, those wells will all have the same concentration, whereas pipetting the buffer stocks directly into the experiment wells introduces variability in buffer concentration. Creating intermediate buffer mixtures does create more Bioworks methods, however it will speed up pipetting overall.
The volume of the buffer mixtures can be normalized. AAO will give the assay developer a count of the number of buffer mixtures needed to complete the experiment. This information will help the assay developer decide which labware is best for the experiment.
ADDITIONAL SOURCE S
In addition to pipetting buffer mixtures and reagent factors, AAO allows the assay developer to add additional sources to be added to the experiment wells. Typically, additional sources are reagents that are common to all experiment wells or to a specific subset of wells, such as Totals or Quality Control wells. AAO will facilitate the creation of Bioworks methods to add those sources. The assay developer has control over the order in which the sources are added, the pipetting parameters, and the location for each source (i.e., Totals, Background, and Standard wells).
PIPETTING PARAMETERS AND LABWARE ASSIGNMENT
When pipetting buffer mixtures, reagent factors, and additional sources, the assay developer needs to set the pipetting parameters for each solution. These include parameters such as tool and tip type, volume, tip changing, etc. This information is needed for AAO to create the corresponding Bioworks methods.
The methods created will pipette the selected sources automatically into appropriate wells using the set parameters. This eliminates need for the assay developer to manually click on all the 'random' locations for that source in each plate.
In addition to the pipetting parameters, the last input needed from the assay developer is the types of labware that will be used for the various sources and destination plates (see Figure 5 ).
METHOD CREATION
Once the pipetting parameter and labware information is set, AAO will assist the assay developer in automatically creating Bioworks methods. The assay developer can select all or a subset of the sources and destinations for which methods will be created. Methods will be created in the order in which the sources are listed. The assay developer is able to change the order as needed. In addition, the assay developer can create methods that are filtered by plate factors, thus allowing for individual treatment of plates with similar inter-plate factor settings.
(4) Perform the Assay Once the Bioworks methods are generated, the researcher can perform the assay. Plates and supplies are manually placed on the Biomek deck for pipetting. Control of other experimental conditions (e.g., temperature or incubation times) will be the responsibility of the researcher. The result of performing these assays generally will be a set plates that can be read on a plate reader during the fifth stage of the process.
BIOM EK 2000 PIPETTING
The researcher has two options for running the pipetting methods created earlier. The first option is to run the methods directly from within AAO. The other option is to run the methods using the Bioworks software. The methods created using AAO can be edited using Bioworks prior to being run with on the Biomek 2000.
To run the method using AAO, the researcher simply selects a method from the list of methods available. At that time, the expected Biomek deck layout will be shown. The researcher will 
PLATE PROCE SSING AND ASSAY SEQUENCING
Pipetting is expected to be a step-wise process. This allows for intermediate experiment steps such as incubation, bulk reagent additions, shaking, etc. Essentially all inter-plate factors are to be handled by the researcher.
Ultimately, the researcher is responsible for sequencing the experiment plates through the assay (i.e., the researcher coordinates the pipetting and non-pipetting steps necessary for the assay). The result of the proper sequencing of the assay is a set of plates ready for measurement.
(5) Collect and Analyze Data
The final stage of AAO is the collection and subsequent analysis of data. This involves AAO automatically creating a Microsoft™ Excel workbook with formulas targeted at indicating those factors or two-factor interactions that make a difference in the assay. This workbook is modifiable for additional analysis. When data has been collected for each plate and statistical analysis has been performed, subsequent experiments can be conducted to identify optimal levels for the factors identified.
DATA COLLECTION
The researcher has two options for collecting data. The first option is automated data entry via SILAS™. SILAS is Beckman Coulter's system integration software. When a SILAS-compatible reader is available, AAO can collect data automatically through SILAS messages generated by that reader's device module.
The other option is manual data entry, although AAO will create and format the worksheet to aid the correct placement of data (see Figure 6 ). The data can be entered into Excel worksheets by typing it in, importing the data file created by a reader, or through an automated means such as an Excel macro. Any post-processing of the data must be performed prior to presenting the Excel worksheet for analysis by AAO. Since all data is stored in Excel worksheets that adhere to a specific format, AAO analyzes data from any source that eventually puts data into such a worksheet.
DATA PROCESSING
AAO can produce different levels of analysis. Depending on the settings used to create them, some levels may not be available for certain experiment sets. When replicates are used, AAO allows the use of average across replicates or the %CV (coefficient of variance as a percentage), to be used as the base data in analysis calculations.
In addition, if the resolution of the experiment design is above Resolution III, and there are not too many factors in the experiment set, then AAO allows the choice of whether or not to include two-factor interactions.
EFFECT ESTIMATION
The Excel workbook produced by AAO allows various levels of analysis. The most primitive analysis is cursory, which involves simply finding the settings used for the "best N" experiments by inspection. The researcher can also use Excel's data filtering tools (e.g., AutoFilter) to list results categorized by certain factor settings. Although neither of these is mathematically sophisticated, they are useful in obtaining basic results.
AAO also provides effect estimation, although the quality (reliability) of the results varies depending on the DOE parameters used to create the experiment set and experimental error. Effect estimation may be used to determine factors that seem statistically significant, as well as those that appear to be statistically insignificant.
CHART CREATION
Normal probability plots of effects and residuals are available for graphical analysis. Pareto charts are also available to help visualize estimated effect magnitude.
SUMMARY
In summary, AAO uses DOE to produce experiment sets that are randomized to prevent introduction of systemic bias into the results. Plate maps are then created assigning the randomized experiments to individual wells. AAO tracks experiments through the entire pipetting and data handling process. Since the plate maps are tracked by AAO, they are used to create the BioWorks methods. Eliminating hand pipetting and manual programming of plate map patterns reduces the time it takes to complete the experiment and minimizes the likelihood of errors.
Once the experiments have been performed, data is collected and correlated with experimental settings (i.e., treatment condi- . This process of "de-randomizing" the experiments and associating them with the appropriate data and treatment conditions is called de-convolution. Lastly, AAO estimates the effect of factors and interactions between factors on the performance of an assay. Effect estimation is the statistical process of extracting this information from the data provided by experimentation. A pictorial summary of the AAO process is shown in Figure 7 .
SAGIAN™ Automated Assay Optimization (AAO) is a dynamic tool for helping assay developers create robust, cost-effective assays. Researchers can run screening designs to discover information about the importance of factors and interactions. Of similar importance is the ability to eliminate factors from further consideration. Factors that do not significantly affect an assay can be set to the least-costly setting and need not be studied in further experimentation.
Making assays more robust for automated systems no longer has to be a bottleneck. With the power of statistical experimental design and analysis, and the speed of automated pipetting for creating experiments, AAO presents the solid structure and simple flexibility to heighten pharmaceutical and biotechnological productivity. With its systematic wizard-like interface, learning and using AAO software is quick and straightforward. The assay developer controls the software -not the other way around. Likewise, with easily created, editable Bioworks methods, the assay developer has full control over the assay process. Finishing an experimental run with automated data collection and an Excel workbook with editable formulas for analysis provides the final, flexible part of the AAO process.
